Top CNS stories for today including the Bridgegate trial leaving few clean from New Jersey political scene; the feds arrest 20 in a crack down on call-center scheme that duped its victims out of hundreds of millions of dollars; Researchers find that bacteria may limit the spread of Zika-carrying mosquitoes, and more.
Sign up for CNS Nightly Brief, a roundup of the day's top stories delivered directly to your email Monday through Friday.
Two former allies of New Jersey Gov. Chris Christie are on trial for politically engineered lane closures that caused massive traffic in September 2013. As the trial unfolded these past six weeks, however, many others have had to wrangle with damaging witness testimony.
Authorities arrested 20 people Thursday on charges that they impersonated IRS and federal immigration officials in phone calls that bilked over 15,000 victims out of hundreds of millions of dollars
Emails leaked by Wikileaks show aides for Hillary Clinton fretted over how the Democratic presidential nominee handled the private email server scandal that emerged right as her primary fight with U.S. Sen. Bernie Sanders began.
Lead defense attorney Maddox Kilgore on Thursday called jurors being allowed to view the SUV in which a toddler died a "disaster," and argued his client, Justin Ross Harris, would not be able to receive a fair trial.
Researchers have come up with a new strategy to limit the spread of Zika: infecting the species of mosquitoes responsible for passing the virus on to humans.
A Michigan circuit court declined to start a grand jury investigation into Gov. Rick Snyder's sue of taxpayer dollars to pay his legal fees in cases related to the Flint water contamination crisis.
ExxonMobil must crack open its accountant's files to comply with New York Attorney General Eric Schneiderman's fraud investigation into the oil giant's knowledge of climate change, a state judge ruled
A Ninth Circuit panel on Wednesday resurrected claims that a pharmaceutical firm hid concerns from investors that its weight-loss drug caused cancer in rats prior to approval by the FDA.